VTE + anticoagulation Flashcards

(52 cards)

1
Q

What is a distal DVT

A

Popliteal vein - behind knee or below

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is a proximal DVT

A

Above the popliteal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Sites of a PE

A

Central #Segmental
Sub segmental

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

COmplications of PE

A

Post thrombotic syndrome
Pulmonary HPTN -> cor pulmonale
Psychological - stress, anxiety et c

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Risk factors PE

A

Cancer
Pregnancy + 6 weeks PP
Surgery - over 30 mins
Fracture, esp if immobile/cast
Flight >4 hours
Recent hospitalisation
Hormone therapy - COCP, HRT
Immobility>3 dyas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How to rule out DVT

A

Low wWells score + negative D dimer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the problem with D dimer

A

High prevalence groups may have negative D dimer and PE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

When is active phase

A

4 weeks after initial
Treatment prevents -> PE or extension of clot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Contraindication for DOACs

A

Impaired renal function, extreme weights, elderly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are LMWH particuarly good for

A

Stopping and starting - immediate effet
eg tinzaparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What drug do you use for a goal INR of 3-4

A

Warfarin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What anticoag use in severe renalimpairment

A

Warfarin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What drug more likely cause ICH and is reversible

A

Warfarin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are clots like in heparin induced thrombocytopenia?

A

Platelet rich white clot (more common arterial disease)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Do you treat sub segmental PE

A

If symptomatic yes #If not detabatable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is budd chiari syndrome

A

Thrombosis of hepatic veins which drain liver -> culminant hepatitis liver failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is portal vein thrombosis

A

Clot in portal veins, bring blood from GI tract into liver - 1/3 of hepatic nutrients/O2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What causes upper limb clots

A

In the upper extremity, 40-80% of clots are related to central venous catheters, and 4% are related to anatomic thoracic outlet obstruction/tight space between subclavian and 1st rib.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Massive eg illiofemoral DVT presentation

A

phlegmasia cerulea dolens (venous gangrene, cyanosis, arterial compromise).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is pleuritic chest pain

A

i.e. sharp, localized, worse when taking a deep breath, persistent;

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Why repeat US in one week for DVT

A

Check for signs of extension/embolisation as often within one week

22
Q

Wells categories DVT

A

1 bedridden > 3day or major surgery past 4 weeks
1 cast/immobilization lower extremity
1 active cancer or cancer treatment past 6 months
1 swelling of entire leg
1 collateral veins
1 tenderness along deep veins
1 pitting oedema greater in symptomatic leg
1 calf swelling >3 cm diameter at 10 cm below tibial tuberosity
-2 alternative diagnosis more likely than DVT

23
Q

Management dependent on Wells

A

-2-0 = low probability
1-2 = moderate probability
>2 = high probability
low or moderate probability: if D-dimer negative, DVT excluded; if D-dimer +, proceed to
compression U/S
high probability: Proceed to U/S. If U/S negative or inconclusive, repeat in 1 week or
consider MRV/venography.

24
Q

Wells categories for PE

A

3.0 – signs/symptoms of DVT
3.0 – alternative diagnosis less likely (to me, practically this often means hypoxaemia
with a clear CXR)
1.5 – previous DVT/PE
1.5 – tachycardia
1.5 – immobilization/plaster cast/surgery past four weeks
1.0 – haemoptysis
1.0 – active malignancy

25
Managemnt depending on Wells score PE
> 4 = PE likely need CTPA or V/Q ≤ 4 = PE unlikely - if D-dimer positive, CTPA or V/Q - if D-dimer negative, PE excluded
26
Investigations lower DVT
Compression US +/-doppler Venography gold standard but rarely done
27
What investigation for isolated iliac vein thrombosis in pregnancy
MR venogram
28
Options for treating VTE
1) DOACs: rivaroxaban, dabigatran, apixaban 2) LMWH 3) Warfarin 4) IV UFH 5) Others- fondaparinux
29
Minimum duration for heparin therapy
5 days AND therapeutic INR x 48 hours
30
Thrombolysis indications in VTE
Massive PE (with hypotension) DVT w plegmasia cerulea dolens Clinical evidence of RHF eg raised JP, unable to ambulate
31
MOA of unfractionated heparin
IIa and Xa binds, 30-60 min onoset of action, immediate if IV
32
Dosage TE treatment UFH in hosptial
80 U/kg IV bolus followed by a rate of 18 U/kg/hour (follow UFH levels)
33
What Creatinine clearance is dangerous for LMWH use?
<20/30ml/min
34
VTE prophylaxis with LMWH
* VTE prophylaxis  Dalteparin: 5,000 U SC OD  Enoxaparin: 40 mg SC OD or 30 mg SC BID. If >100kg, 60 mg SC OD  Tinzaparin: 35-55 kg: 3500 U SC OD, 56-100 kg: 4500 U SC OD
35
VTE treatment with LMWH
* VTE treatment  Dalteparin: 200 U/kg SC OD or 100 U/kg SC BID  Enoxaparin: 1.5 mg/kg SC OD or 1 mg/kg SC BID  Tinzaparin - 175 U/kg SC OD
36
Monitoring on LMWH
CBC and CrC Not routinely required unless obese, renal dysfunction, unexplained bleeding, breakthrough thrombosis, regnancy
37
Common indications for warfarin
Stroke prevention AF Long term secondary prevention of VTE Prevention of thrombosis or systemic embolisation in patients with mechanical heart valves
38
Metabolism of warfarin
CYP450
39
Renal concerns with warfarin
No need to cahnge dose CKD can increase bleeding risk
40
What INR goal for patients with mechanica heart vlave
INR 2.5-3.5
41
Complications of warfarin treatment
Warfarin skin necrosis Purple toe syndrome Tetraogenic in first trimester - crosses placenta
42
What is apixaban
Xa inhibitor
43
Half life and onset of apixaban
12 hour half life (longer in elderly) Rapid onset of action 30 mins with peak effect at 3-4 hours
44
Metabolism of apixabam
CYP3A4 and P-gp substrate
45
Whaat drugs avoid with apixaban
CYP3A4 inhibitors - increase serum concentration of apixaban CYP3A4 inducers - decrease
46
Dosing of apixaban
* VTE treatment: 10mg PO BID for 7 days, then 5mg PO BID (does not require initial heparin or LMWH) * Reduction in risk of VTE recurrence: 2.5mg PO BID after at least 6 months of treatment * VTE prophylaxis: 2.5mg PO BID, start 12-24 hours post-op if hemostasis achieved * Atrial fibrillation: 5mg PO BID or 2.5mg PO BID if 2 out of 3 of the following – Age ≥ 80 years, weight ≤ 60kg or serum creatinine ≥ approximately 133 μmol/L
47
Renal adjusments with apixaban
Dose adjust in mild to mod renal impairment Not recommended if severe eg CrCl <25ml/min
48
Liver CIs with apixaban
ALT/AST 2-3x upper limit Bilirubin >1.5 x ULN
49
Dabigatran MOA
Direct thrombin inhibitor
50
Onset of dabigatran
T½ approximately 8-12 hours (prolonged in elderly); Rapid onset ofaction 30 minutes with peak effect at 2 hours;
51
Can you use other CYP enzyme metabolised drugs with dabigatran
Yes - not metabolised by them
52